Medications

Tackling the high cost of prescription drugs

The high cost of prescription drugs in the United States came under scrutiny in a new report from the National Academies of Sciences, Engineering, and Medicines, "Making Medicines Affordable: A National Imperative," co-authored ...

Diseases, Conditions, Syndromes

Glaxo plant with Legionnaires' bacteria is quiet for second day

All was quiet Wednesday at a GlaxoSmithKline pharmaceutical plant that was shut down after the drug maker discovered the bacteria that cause potentially fatal Legionnaires' disease in a cooling tower at the site.

Other

AstraZeneca fends off Pfizer with new growth plan

AstraZeneca on Tuesday outlined plans to make sales jump over the next decade, an effort to persuade shareholders the drug maker can do well as an independent company, rather than get bought out by rival Pfizer.

Medications

Endo Health to pay $192.7M in gov't settlement

Endo Health will pay almost $193 million to resolve claims that it improperly marketed the shingles treatment Lidoderm for unapproved uses like treating lower back pain.

page 6 from 7